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Computed tomography and magnetic resonance imaging-based techniques of functional
imaging are proven to be sensitive and reliable tools for detection and staging of head and
neck cancer.
These new techniques enable to visualize and differentiate subtle pathologic changes
before they become evident on standard cross-sectional images.
However, it is their role in evaluating possible recurrence and estimation of treatment
response that holds the biggest promise.erfusion imaging
iffusion-weighted imaging
unctional imaging
quamous cell carcinoma
ecurrence
This article describes the role and usefulness of diffusion and perfusion in detecting
recurrence and follow-up in patients with head and neck squamous cell carcinoma.
© 2011 Greater Poland Cancer Centre, Poland. Published by Elsevier Urban & Partner Sp.
z.o.o. All rights reserved.
and neck radiology, used to say that there are three basic. Introduction
ead and neck imaging has been revolutionized during last 20
ears. In squamous cell carcinoma (SCC), multislice computed
omography (CT) and new sequences in magnetic resonance
MR) imaging help in tumor staging, which inﬂuences patient
anagement andprognosis. New imagingmodalities have the
bility to differentiate neoplastic from inﬂammatory lesions;
rovide essential information about the deep extension of
linically detected masses and delineate additional clinically
nsuspected lesions.1–6 They have proven accuracy in detec-
ion of soft tissue extent, lymph node involvement, bone
arrow inﬁltration and perineural spread.5–10
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oi:10.1016/j.rpor.2011.06.006The latest developments in imaging patientswithhead and
neck SCC are based on the observation that most patholog-
ical processes become evident before they proceed in gross
anatomical distortion. Methods of functional imaging depict
and differentiate diseases by assessing functional (vascular-
ization, blood ﬂow, lymphatic ﬂow), metabolic (e.g. glycolysis)
ormolecular phenomena (proliferation, epidermal growth fac-
tor receptor expression and apoptosis). This information is
readily used for the detection of recurrent disease and assess-
ment of early response.
AntonioMancuso, one of America’s leading experts in headstrategies in the war against head and neck squamous cell
cancer.11 The ﬁrst one is prevention. The second one is to kill
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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the cancer completely the ﬁrst time it is treated. The third
strategy is the salvage of initial treatment failures. All physi-
cians who treat head and neck cancer realize that salvage
comes at a considerable cost in terms of increased morbidity
and markedly diminished chances of disease-free survival at
most primary sites.When tumor recurs, it will usually be difﬁ-
cult to recognizewithindeformed tissues or post-radiotherapy
changes. It may also be biologically more aggressive and will
have a tendency to spread along nerves and vessels. A fail-
ure at the primary site then must be discovered early, before
its margins become untreatably diffused into surrounding tis-
sues, if there is to be a reasonable hope for successful salvage.
The risk of developing local or regional recurrence or dis-
tant metastases remains high, despite aggressive surgical and
radiotherapy treatment3,6; since the early 1990s, many radio-
logical studies have been performed and their potential in the
detection of recurrent cancer is being evaluated.
Nowadays, we have a broad availability of tools for detect-
ing asymptomatic recurrence. Having more experience and
more data concerning the value of functional imaging, we
must begin to apply these techniques as part of strategy in
the war against head and neck cancer.11
2. Perfusion imaging
Perfusion is deﬁned as blood ﬂow through a unit volume
of tissue per unit of time.2,8,12 Perfusion imaging may be
performed with either CT or MR. This technique adds little
time to conventional MR/CT examinations and can also be
obtained noninvasively. Following 30–60 s. of dynamic acqui-
sition, basic parameters of perfusion – blood ﬂow (BF), blood
volume (BV), mean transit time (MTT), time to peak (TTP) and
permeability surface (PS) can be generated mathematically
by a computer, on a separate workstation with commercially
available software. Perfusion characteristics of tissue usu-
ally demonstrate changes in blood ﬂow or blood volume in
a pre-deﬁned region of interest, depending on the underly-
ing pathologic processes. This technique has been previously
Fig. 1 – A case of hypopharyngeal squamous cell carcinoma. Axi
and pathological mass is visible in the right pyriform sinus apex
The area of a high blood ﬂow (mean value=132ml/100g/min), re
pyriform sinus apex, postcricoid area and along the right thyroid
area of elevated blood volume (mean value=5.72ml/100g) is maiotherapy 1 6 ( 2 0 1 1 ) 207–212
studied in characterizing brain ischemia, particularly in iden-
tifying infarcted tissue versus penumbra.13 Neoplastic tissue
also demonstrates noticeable changes in perfusion parame-
ters. Some studies have shown that squamous cell carcinoma
of the oral cavity/oropharynx demonstrated increased blood
volume and blood ﬂow in comparison to normal tissue12,14
(Fig. 1). These ﬁndings have been attributed to tumor’s neo-
vascularity. Also, other studies have proven, thatwith analysis
of perfusion parameters of a given structure, it is possible
to depict malignant inﬁltration before it becomes visible in
standard cross-sectional imaging.15 Generally, these ﬁndings
will add substantial additional information regarding tumor
extent and staging. Such imaging may also be useful in qual-
itative analysis of tumor tissue. In a very recent study by
Faggioni et al.,14 the role of computed tomography perfusion
(CTP) was evaluated with 64-row multislice CT. Data from this
study showed that CTP could provide useful information for
differentiation between SCC and normal tissue. The authors
found signiﬁcantly higher BF and BV values in SCC compared
to normal tissue. This ﬁnding was attributed to the enlarged
neovascular bed as a consequence of tumoral neoangiogene-
sis. This holds promise for a better delineation of the extent
of tumor, more accurate staging and earlier depiction of squa-
mous cell carcinoma recurrence.
The evaluation of perfusion images clearly improves the
depiction of malignant inﬁltration of muscles, with much
better overall results when compared to standard CT/MR
images.12,14,15 These standard modalities may fail to depict
small areas of malignant tissue and may be unable to distin-
guish tumor from inﬂammation, but there is evidence, that
the combined use of CT/MR and perfusion results in correct
staging of the majority of head and neck tumors and accurate
detection of recurrence.
Recent studies have demonstrated that squamous cell
carcinomas of head and neck, with increased blood vol-
ume/ﬂow, are more chemosensitive than other lesions with
relatively decreased perfusion parameters.16 This is proba-
bly due to increased oxygenation and metabolism in such
lesions. In viewof these ﬁndings, perfusion techniquesmay be
al contrast-enhanced CT scan. Slight contrast enhancement
and postcricoid area (arrows). Perfusion map of blood ﬂow.
presenting malignant inﬁltration, is visible in right
cartilage (arrows). Perfusion map of blood volume. The
rked with arrows and represents malignant inﬁltration.
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articularly useful in determining which patients would ben-
ﬁt from such medical treatment, as opposed to surgical
herapies which may not always preserve organ func-
ion. It has been described by Surlan-Popovic18 that during
hemotherapy responders show a signiﬁcant constant reduc-
ion of BF and signiﬁcant initial reduction of BV, while
on-responders demonstrate an acute increase of BF, BV and
S. In patients receiving induction chemotherapy, tumorswith
igh values of BV (>5.0ml/100ml) respond much better than
umors with low BV.
Another special area of interest is the question of tumor
ecurrence. Evaluation of post-treatment neck remains chal-
enging despite availability of modern imaging studies.
ostradiotherapy changes include ﬁbrosis, edema, and soft
issue thickening, sometimes also necrosis. In this setting,
he identifying recurrent tumor and distinguishing between
arcinoma and a benign process is usually very challeng-
ng. Also, many recurrences present with multicentric tumor
oci, localized below unchanged mucosa, and masked by
ost-treatment edema. Conventional CT and MRI do not
llow precise differentiation between recurrent tumor and the
ost (chemo)radiotherapy changes. They would demonstrate
ncreased contrast enhancement within the treated neck, but
hismay be due to persistent inﬂammation, edema or ﬁbrosis.
ecent studies have demonstrated that in cases of recurrent
quamous cell carcinomas CT perfusion may play a signiﬁ-
ant role in the detection of malignant tissue. This technique
ay permit better differentiation between local tumor recur-
ence and nonspeciﬁc post-therapy tissue changes. As shown
y Bisdas and Hermans,16–19 values of perfusion parameters
re signiﬁcantly higher in tumor tissue comparedwith normal
tructures, including tissue changes after chemoradiotherapy.
peciﬁcally, blood volume and blood ﬂow values within recur-
ent tumor are markedly elevated (Fig. 2).19
. Diffusion imagingiffusion-weighted imaging (DWI) is one of the best investi-
ated tools for detection and characterization of tumors in the
ig. 2 – A case of left-sided retromolar trigone carcinoma. Axial c
n the oral cavity and oropharynx. Perfusion map of blood ﬂow. T
alue=103ml/100g/min), representing malignant submucosal in
haryngeal mucosal space and buccal space (arrows). Perfusion m
mean value=4.6ml/100g), is marked with arrows and representtherapy 1 6 ( 2 0 1 1 ) 207–212 209
last few years. Technical improvements and higher magnetic
ﬁelds have accelerated research in diffusion techniques.2
DWI is anoninvasive technique that characterizes tissue on
the basis of differences in tissue water mobility. The motion
of tissue water molecules caused by their thermal kinetic
energy (Brownian motion) is limited by the presence of cel-
lular membranes and macromolecules. Diffusion-weighted
images are obtained by applying pairs of opposing magnetic
ﬁeld gradients around the refocusing pulse of a T2-weighted
sequence. Water molecules will be dephased by the ﬁrst gra-
dient and rephased by the second gradient. If the water
molecules are stationary, no net dephasing is expected. Move-
ment of the tissue water molecules between the two opposing
gradients will result in dephasing, depicted as a signal loss
on the diffusion-weighted images.9,19 The amount of signal
loss is proportional to the degree of water molecule move-
ment, as well as the strength and duration of the applied
gradients. This last factor is expressed by the b-value. By
repeating the sequence with different b-values, the signal
loss can be quantiﬁed by calculating the apparent diffusion
coefﬁcient (ADC).
Hypercellular tissue, which is present within malignant
tumors, has low ADC values (Fig. 3). Changes in tissue, like
edema, inﬂammation and necrosis, are expected to have low
cellularity and demonstrate high ADC values, as clinically
validated.5,10,20–22
A promising application of DWI for head and neck cancer
is to make the distinction between post-treatment changes
after radiotherapy and tumor recurrence (Figs. 4 and 5).
Because the recurrence rates after (chemo)radiotherapy for
advanced-stage tumors (T3 and T4) range from 25% to 50%,
early diagnosis of cancer recurrence is essential. Several
studies have demonstrated that diffusion-weightedMRI deliv-
ers promising results in differentiation between recurrent
head and neck tumors and postoperative or postradia-
tion changes.18,19 Signal intensity on native b0 images is
signiﬁcantly lower for cancer than for non-tumoral post-
radiotherapeutic tissue. Signal intensity on native b1000
images is signiﬁcantly higher for cancer than for non-tumoral
tissue. ADC values are signiﬁcantly lower for cancer than
ontrast-enhanced CT scan showing no visible abnormality
he area of a high blood ﬂow (mean
ﬁltration, is visible in the left retromolar trigone area,
ap of blood volume. The area of a high blood volume
s malignant inﬁltration.
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Fig. 3 – A case of left-sided laryngeal cancer with lymph nodes metastases (images courtesy of B. Bobek-Billewicz). (A) Axial
T1-weighted MR image, with contrast enhancement. Pathological subglottic mass is visible (arrow); large metastatic lymph
node is also visible on the left side (two arrows). (B and C) Diffusion-weighted images, b0 and b1200, respectively. Both the
tumor and the lymph node show a persisting high signal on the b1200 image, indicating diffusion restriction. These
ﬁndings are strongly indicative of the presence of malignant tissue and metastatic adenopathy. (D) Corresponding ADC-map
reveals low ADC-values in the tissue and in the node, indicating presence of diffusion restriction.for non-tumoral tissue. When compared with computed
tomography and FDG-PET, DW-MRI has higher sensitivity and
better accuracy in detecting recurrence; it also has fewer
false-positive results in persistent primary site abnormalities
and in persistent adenopathies.22 It may help in the detec-
tion of subcentimetric nodal metastases. Overall, the method
seems superior to CT, classical MR or other functional studies
(positron emission tomography) for the differential diagnosis
in post-treatment setting.
However, as stated by Hermans and Vandecaveye,5,9,19 the
difﬁcult interpretation of DWI in the head and neck and the
lack of method standardization to date are a true challenge,
and one needs a lot of additional work to make this technique
efﬁcient for routine use. Also, this technique is sensitive to
artifacts whichmay substantially reduce the quality of images
at the level of skull base and thoracic inlet.Another issue is the characterization of neck lymph nodes,
which remains a difﬁcult issue with anatomy-based imaging
methods.23 DWIholds promise in this regard.5,22,24 On theADC
map,malignant nodes usually show a low signal intensity and
benignnodes reveal high signal intensity. ThemeanADCvalue
ofmetastatic lymph nodes tends to be signiﬁcantly lower than
that of benign cervical lymph nodes. When the ADC value
of 1.38×10−3 mm2/s is used as a threshold value for differ-
entiating malignant from benign lymph nodes, the accuracy
for detecting metastatic nodes reaches 96%, sensitivity 98%,
speciﬁcity 88%, and the positive predictive value is as high as
98.5%.
In conclusion, diffusion-weighted MRI with ADC mapping
is a new promising technique that can differentiatemalignant
from benign lymph nodes and delineate the solid viable part
of the lymph node for biopsy.
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Fig. 4 – A case of left hypopharyngeal carcinoma treated with radiotherapy, follow-up study, 6 months after completion of
treatment (images courtesy of B. Bobek-Billewicz). Axial contrast-enhanced MR image, no visible area of pathological
contrast enhancement is visible diffusion-weighted b0 image, which is symmetric with no areas of restricted diffusion.
Diffusion-weighted b1200 image, showing no areas of diffusion restrictions, which indicates a complete remission and
successful treatment.
Fig. 5 – A case of left-sided ﬂoor of the mouth carcinoma, treated with chemo-radiotherapy, follow-up study 8 months after
completion of treatment (images courtesy of B. Bobek-Billewicz). Axial contrast-enhanced MR image, distinct area of
pathological contrast enhancement is visible on the left side (arrows). Diffusion-weighted b1200 image; area of persisting
high signal is visible, indicating diffusion restriction (arrow); this indicates the presence of malignant tissue. Corresponding
ADC map, which reveals low ADC values in the tissue (arrow), indicating the presence of restricted diffusion and suggesting
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As DWI allows differentiation between inﬂammatory
nd neoplastic tissue, another possible application could
e the monitoring of tumor response during radiotherapy.
or instance, high pretreatment ADC values are suggestive
f necrosis, which may predict poor outcomes because of
ypoxia-mediated radioresistance. Some recent studies4,15
ave demonstrated, that cellular death and vascular changes
aused by therapy could be detected by DWI before a reduc-
ion of lesion diameter becomes apparent at morphological
maging. However, DWI based on many b-values and ADC
easurements should be used as an adjunctive, but not sub-
titutive, tool to the standard MR imaging examination to
ssess the response of cancer to non-surgical treatment. The
ossibility of distinguishing responders fromnon-responders,
s well as early identiﬁcation of non-responder tumors, would
elp in addressing cervical cancer patients to stop ineffective
reatments and to avoid delays in starting alternative, poten-
ially more effective treatments.4. Conclusion
Imaging postsurgical and post-radiotherapy patients can be
challenging due to anatomical alterations and post-treatment
changes. Also, clinical evaluation of such patients remains
difﬁcult. The knowledge about new powerful techniques of
functional imaging, their advantages and their proper appli-
cation will help to improve the salvage rate and will reduce
the morbidity of treatment for recurrent head and neck squa-
mous cell cancer, by earlier and more reliable detection of
residual/recurrent disease.
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